Journal of Clinical Oncology, Vol 12, 843-850, Copyright © 1994 by American Society of Clinical Oncology

ARTICLES

Attitudes about genetic testing for breast-ovarian cancer susceptibility

C Lerman, M Daly, A Masny and A Balshem
Lombardi Cancer Research Center, Georgetown University Medical Center, Washington, DC 20007.

PURPOSE: In anticipation of the availability of genetic testing for a breast-ovarian cancer susceptibility gene (BRCA1), this study examined interest in and expectations about the impact of a potential genetic test. PATIENTS AND METHODS: The subjects were 121 first-degree relatives (FDRs) of ovarian cancer patients. The design was cross- sectional. Subjects completed a structured telephone interview of attitudes about cancer and genetic testing, and self-report psychologic questionnaires to assess coping style and mood disturbance. RESULTS: Overall, 75% of FDRs said that they would definitely want to be tested for BRCA1 and 20% said they probably would. In bivariate analyses, interest was associated positively with education, perceived likelihood of being a gene carrier, perceived risk of ovarian cancer, ovarian cancer worries, and mood disturbance. In logistic regression analysis, perceived likelihood of being a gene carrier was associated strongly with interest (odds ratio, 3.7; P = .006). Results of stepwise linear regression modeling indicated that an anticipated negative impact of genetic testing was associated with being younger (beta = -.66, P = .009), having more mood disturbance (beta = .015, P = .01), and having an information-seeking coping style (beta = .19, P = .002). CONCLUSION: These results suggest that the demand for genetic testing for BRCA1 among FDRs of cancer patients may be great. Moreover, those who elect to participate may represent a more psychologically vulnerable subgroup of high-risk women.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. N. Peshkin, T. A. DeMarco, J. E. Garber, H. B. Valdimarsdottir, A. F. Patenaude, K. A. Schneider, M. D. Schwartz, and K. P. Tercyak Brief Assessment of Parents' Attitudes Toward Testing Minor Children for Hereditary Breast/Ovarian Cancer Genes: Development and Validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS) J. Pediatr. Psychol., July 1, 2009; 34(6): 627 - 638. [Abstract] [Full Text] [PDF]

				N. T. Brewer, J. P. Tzeng, S. E. Lillie, A. S. Edwards, J. M. Peppercorn, and B. K. Rimer Health Literacy and Cancer Risk Perception: Implications for Genomic Risk Communication Med Decis Making, March 1, 2009; 29(2): 157 - 166. [Abstract] [PDF]

				S. C. O'Neill, N. T. Brewer, S. E. Lillie, E. F. Morrill, E. C. Dees, L. A. Carey, and B. K. Rimer Women's Interest in Gene Expression Analysis for Breast Cancer Recurrence Risk J. Clin. Oncol., October 10, 2007; 25(29): 4628 - 4634. [Abstract] [Full Text] [PDF]

				J. B. Madalinska, M. van Beurden, E. M.A. Bleiker, H. B. Valdimarsdottir, L. Lubsen-Brandsma, L. F. Massuger, M. J.E. Mourits, K. N. Gaarenstroom, E. B.L. van Dorst, H. van der Putten, et al. Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1/2 Mutation Carriers J. Clin. Oncol., January 20, 2007; 25(3): 301 - 307. [Abstract] [Full Text] [PDF]

				M. E. Ropka, J. Wenzel, E. K. Phillips, M. Siadaty, and J. T. Philbrick Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 840 - 855. [Abstract] [Full Text] [PDF]

				P. A. Parker, L. Cohen, V. A. Bhadkamkar, R. J. Babaian, M. A. Smith, E. R. Gritz, and K. M. Basen-Engquist Demographic and Past Screening Behaviors of Men Attending a Free Community Screening Program for Prostate Cancer Health Promot Pract, April 1, 2006; 7(2): 213 - 220. [Abstract] [PDF]

				C. H. Halbert, O. H. Gandy Jr., A. Collier, and L. Shaker Intentions to Participate in Genetics Research among African American Smokers Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 150 - 153. [Abstract] [Full Text] [PDF]

				L. d'Agincourt-Canning Genetic Testing for Hereditary Breast and Ovarian Cancer: Responsibility and Choice Qual Health Res, January 1, 2006; 16(1): 97 - 118. [Abstract] [PDF]

				C. H. Halbert, K. Brewster, A. Collier, C. Smith, L. Kessler, B. Weathers, J. E. Stopfer, S. Domchek, and E. P. Wileyto Recruiting African American Women to Participate in Hereditary Breast Cancer Research J. Clin. Oncol., November 1, 2005; 23(31): 7967 - 7973. [Abstract] [Full Text] [PDF]

				A. C. Hurley, R. Harvey, J. S. Roberts, C. Wilson-Chase, S. Lloyd, J. Prest, M. Lock, K. J. Horvath, and R. C. Green Genetic susceptibility for Alzheimer's disease: Why did adult offspring seek testing? American Journal of Alzheimer's Disease and Other Dementias, November 1, 2005; 20(6): 374 - 381. [Abstract] [PDF]

				J. B. Madalinska, J. Hollenstein, E. Bleiker, M. van Beurden, H. B. Valdimarsdottir, L. F. Massuger, K. N. Gaarenstroom, M. J.E. Mourits, R. H.M. Verheijen, E. B.L. van Dorst, et al. Quality-of-Life Effects of Prophylactic Salpingo-Oophorectomy Versus Gynecologic Screening Among Women at Increased Risk of Hereditary Ovarian Cancer J. Clin. Oncol., October 1, 2005; 23(28): 6890 - 6898. [Abstract] [Full Text] [PDF]

				A. D. Gurmankin, S. Domchek, J. Stopfer, C. Fels, and K. Armstrong Patients' Resistance to Risk Information in Genetic Counseling for BRCA1/2 Arch Intern Med, March 14, 2005; 165(5): 523 - 529. [Abstract] [Full Text] [PDF]

				L. A. Keogh, M. C. Southey, J. Maskiell, M.-A. Young, C. L. Gaff, J. Kirk, K. M. Tucker, D. Rosenthal, M. R.E. McCredie, G. G. Giles, et al. Uptake of Offer to Receive Genetic Information about BRCA1 and BRCA2 Mutations in an Australian Population-Based Study Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2258 - 2263. [Abstract] [Full Text] [PDF]

				J Balmana, E M Stoffel, K M Emmons, J E Garber, and S Syngal Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes J. Med. Genet., April 1, 2004; 41(4): e44 - e44. [Full Text] [PDF]

				N. Peters, A. Rose, and K. Armstrong The Association between Race and Attitudes about Predictive Genetic Testing Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 361 - 365. [Abstract] [Full Text]

				E Sermijn, G Goelen, E Teugels, L Kaufman, M Bonduelle, B Neyns, B Poppe, A De Paepe, and J De Greve The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation J. Med. Genet., March 1, 2004; 41(3): e23 - 23. [Full Text] [PDF]

				L. Cohen, R. T. Fouladi, R. J. Babaian, V. A. Bhadkamkar, P. A. Parker, C. C. Taylor, M. A. Smith, E. R. Gritz, and K. Basen-Engquist Cancer Worry Is Associated with Abnormal Prostate-specific Antigen Levels in Men Participating in a Community Screening Program Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 610 - 617. [Abstract] [Full Text] [PDF]

				E M A Bleiker, F H Menko, B G Taal, I Kluijt, L D V Wever, M A Gerritsma, H F A Vasen, and N K Aaronson Experience of discharge from colonoscopy of mutation negative HNPCC family members J. Med. Genet., May 1, 2003; 40(5): e55 - 55. [Full Text] [PDF]

				D. W. Hadley, J. Jenkins, E. Dimond, K. Nakahara, L. Grogan, D. J. Liewehr, S. M. Steinberg, and I. Kirsch Genetic Counseling and Testing in Families With Hereditary Nonpolyposis Colorectal Cancer Arch Intern Med, March 10, 2003; 163(5): 573 - 582. [Abstract] [Full Text] [PDF]

				S. J. Cutler and L. G. Hodgson To test or not to test: Interest in genetic testing for Alzheimer's disease among middle-aged adults American Journal of Alzheimer's Disease and Other Dementias, January 1, 2003; 18(1): 9 - 20. [Abstract] [PDF]

				D G R Evans and F Lalloo Risk assessment and management of high risk familial breast cancer J. Med. Genet., December 1, 2002; 39(12): 865 - 871. [Abstract] [Full Text] [PDF]

				B. N. Peshkin, M. D. Schwartz, C. Isaacs, C. Hughes, D. Main, and C. Lerman Utilization of Breast Cancer Screening in a Clinically Based Sample of Women after BRCA1/2 Testing Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1115 - 1118. [Abstract] [Full Text] [PDF]

				D J MacDonald, J Choi, B Ferrell, S Sand, S McCaffrey, K R Blazer, M Grant, and J N Weitzel Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment J. Med. Genet., July 1, 2002; 39(7): 526 - 530. [Full Text] [PDF]

				C J van Asperen, S van Dijk, M W Zoeteweij, D R M Timmermans, G H de Bock, E J Meijers-Heijboer, M F Niermeijer, M H Breuning, J Kievit, and W Otten What do women really want to know? Motives for attending familial breast cancer clinics J. Med. Genet., June 1, 2002; 39(6): 410 - 414. [Full Text] [PDF]

				J. L. Bottorff, P. A. Ratner, L. G. Balneaves, C. G. Richardson, M. McCullum, T. Hack, K. Chalmers, and J. Buxton Women's Interest in Genetic Testing for Breast Cancer Risk: The Influence of Sociodemographics and Knowledge Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 89 - 95. [Abstract] [Full Text]

				V. Bonadona, P. Saltel, F. Desseigne, H. Mignotte, J.-C. Saurin, Q. Wang, O. Sinilnikova, S. Giraud, G. Freyer, H. Plauchu, et al. Cancer Patients Who Experienced Diagnostic Genetic Testing for Cancer Susceptibility: Reactions and Behavior after the Disclosure of a Positive Test Result Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 97 - 104. [Abstract] [Full Text]

				Y. MURAKAMI, N. GONDO, H. OKAMURA, T. AKECHI, and Y. UCHITOMI Guilt From Negative Genetic Test Findings Am J Psychiatry, November 1, 2001; 158(11): 1929 - 1929. [Full Text] [PDF]

				N. Hallowell, I. Jacobs, M. Richards, J. Mackay, and M. Gore Surveillance or surgery? A description of the factors that influence high risk premenopausal women's decisions about prophylactic oophorectomy J. Med. Genet., October 1, 2001; 38(10): 683 - 691. [Full Text] [PDF]

				M Welkenhuysen, G Evers-Kiebooms, M Decruyenaere, E Claes, and L Denayer A community based study on intentions regarding predictive testing for hereditary breast cancer J. Med. Genet., August 1, 2001; 38(8): 540 - 547. [Full Text] [PDF]

				J. S. Shaw III and K. L. Bassi Lay Attitudes toward Genetic Testing for Susceptibility to Inherited Diseases J Health Psychol, July 1, 2001; 6(4): 405 - 423. [Abstract] [PDF]

				K. Bosompra, T. Ashikaga, B. S. Flynn, J. K. Worden, and L. J. Solomon Psychosocial factors associated with the public's willingness to pay for genetic testing for cancer risk: a structural equations model Health Educ. Res., April 1, 2001; 16(2): 157 - 172. [Abstract] [Full Text] [PDF]

				L. D. Cameron and M. A. Diefenbach Responses to Information about Psychosocial Consequences of Genetic Testing for Breast Cancer Susceptibility: Influences of Cancer Worry and Risk Perceptions J Health Psychol, January 1, 2001; 6(1): 47 - 59. [Abstract] [PDF]

				R. E. Myers, T. Hyslop, K. Jennings-Dozier, T. A. Wolf, D. Y. Burgh, J. A. Diehl, C. Lerman, and G. W. Chodak Intention to Be Tested for Prostate Cancer Risk among African-American Men Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1323 - 1328. [Abstract] [Full Text]

				A. W. Helmes, D. J. Bowen, R. Bowden, and J. Bengel Predictors of Participation in Genetic Research in a Primary Care Physician Network Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1377 - 1379. [Abstract] [Full Text]

				H. J. Smedira Practical Issues in Counseling Healthy Women About Their Breast Cancer Risk and Use of Tamoxifen Citrate Arch Intern Med, November 13, 2000; 160(20): 3034 - 3042. [Abstract] [Full Text] [PDF]

				K. Armstrong, K. Calzone, J. Stopfer, G. Fitzgerald, J. Coyne, and B. Weber Factors Associated with Decisions about Clinical BRCA1/2 Testing Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1251 - 1254. [Abstract] [Full Text]

				K. A Metcalfe, A. Liede, E. Hoodfar, A. Scott, W. D Foulkes, and S. A Narod An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling J. Med. Genet., November 1, 2000; 37(11): 866 - 874. [Abstract] [Full Text]

				L HUMPHREYS, A G W HUNTER, A ZIMAK, A O'BRIEN, Y KORNELUK, and M CAPPELLI Why patients do not attend for their appointments at a genetics clinic J. Med. Genet., October 1, 2000; 37(10): 810 - 815. [Full Text]

				E. T. Matloff, H. Shappell, K. Brierley, B. A. Bernhardt, W. McKinnon, and B. N. Peshkin What Would You Do? Specialists' Perspectives on Cancer Genetic Testing, Prophylactic Surgery, and Insurance Discrimination J. Clin. Oncol., June 12, 2000; 18(12): 2484 - 2492. [Abstract] [Full Text] [PDF]

				B. MEISER, P. BUTOW, A. BARRATT, G. SUTHERS, M. SMITH, A. COLLEY, E. THOMPSON, and K. TUCKER Attitudes to genetic testing for breast cancer susceptibility in women at increased risk of developing hereditary breast cancer J. Med. Genet., June 1, 2000; 37(6): 472 - 476. [Full Text]

				M. Dorval, A. F. Patenaude, K. A. Schneider, S. A. Kieffer, L. DiGianni, K. J. Kalkbrenner, J. I. Bromberg, L. A. Basili, K. Calzone, J. Stopfer, et al. Anticipated Versus Actual Emotional Reactions to Disclosure of Results of Genetic Tests for Cancer Susceptibility: Findings From p53 and BRCA1 Testing Programs J. Clin. Oncol., May 10, 2000; 18(10): 2135 - 2142. [Abstract] [Full Text] [PDF]

				K. Brain, J. Gray, P. Norman, E. Parsons, A. Clarke, C. Rogers, R. Mansel, and P. Harper Why do women attend familial breast cancer clinics? J. Med. Genet., March 1, 2000; 37(3): 197 - 202. [Abstract] [Full Text]

				L. G. Hodgson, S. J. Cutler, and K. Livingston Alzheimer's disease and symptom-seeking American Journal of Alzheimer's Disease and Other Dementias, November 1, 1999; 14(6): 364 - 374. [Abstract] [PDF]

				K. Glanz, J. Grove, L. Le Marchand, and C. Gotay Underreporting of Family History of Colon Cancer: Correlates and Implications Cancer Epidemiol. Biomarkers Prev., July 1, 1999; 8(7): 635 - 639. [Abstract] [Full Text]

				I. M. Lipkus, D. Iden, J. Terrenoire, and J. R. Feaganes Relationships among Breast Cancer Concern, Risk Perceptions, and Interest in Genetic Testing for Breast Cancer Susceptibility among African-American Women with and without a Family History of Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 533 - 539. [Abstract] [Full Text]

				K. Glanz, J. Grove, C. Lerman, C. Gotay, and L. L. Marchand Correlates of Intentions to Obtain Genetic Counseling and Colorectal Cancer Gene Testing Among At-Risk Relatives from Three Ethnic Groups Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 329 - 336. [Abstract] [Full Text] [PDF]

				G. M. Petersen, E. Larkin, A.-M. Codori, C.-Y. Wang, S. V. Booker, J. Bacon, F. M. Giardiello, and P. A. Boyd Attitudes toward Colon Cancer Gene Testing: Survey of Relatives of Colon Cancer Patients Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 337 - 344. [Abstract] [Full Text] [PDF]

				A.-M. Codori, G. M. Petersen, D. L. Miglioretti, E. K. Larkin, M. T. Bushey, C. Young, J. D. Brensinger, K. Johnson, J. A. Bacon, and S. V. Booker Attitudes toward Colon Cancer Gene Testing: Factors Predicting Test Uptake Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 345 - 351. [Abstract] [Full Text] [PDF]

				S. W. Vernon, E. R. Gritz, S. K. Peterson, C. A. Perz, S. Marani, C. I. Amos, and W. F. Baile Intention to Learn Results of Genetic Testing for Hereditary Colon Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 353 - 360. [Abstract] [Full Text] [PDF]

				C. Lerman, C. Hughes, J. L. Benkendorf, B. Biesecker, J. Kerner, J. Willison, N. Eads, D. Hadley, and J. Lynch Racial Differences in Testing Motivation and Psychological Distress following Pretest Education for BRCA1 Gene Testing Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 361 - 367. [Abstract] [Full Text] [PDF]

				S. J. Durfy, D. J. Bowen, A. McTiernan, J. Sporleder, and W. Burke Attitudes and Interest in Genetic Testing for Breast and Ovarian Cancer Susceptibility in Diverse Groups of Women in Western Washington Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 369 - 375. [Abstract] [Full Text] [PDF]

				M. Daly, J. Farmer, C. Harrop-Stein, S. Montgomery, M. Itzen, J. W. Costalas, A. Rogatko, S. Miller, A. Balshem, and D. Gillespie Exploring Family Relationships in Cancer Risk Counseling Using the Genogram Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 393 - 398. [Abstract] [Full Text] [PDF]

				L. G. Bluman, B. K. Rimer, D. A. Berry, N. Borstelmann, J. D. Iglehart, K. Regan, J. Schildkraut, and E. P. Winer Attitudes, Knowledge, and Risk Perceptions of Women With Breast and/or Ovarian Cancer Considering Testing for BRCA1 and BRCA2 J. Clin. Oncol., March 1, 1999; 17(3): 1040 - 1040. [Abstract] [Full Text] [PDF]

				R. T. Croyle and C. Lerman Risk Communication in Genetic Testing for Cancer Susceptibility J Natl Cancer Inst Monographs, January 1, 1999; 1999(25): 59 - 66. [Abstract] [Full Text]

				G. Geller, J. R. Botkin, M. J. Green, N. Press, B. B. Biesecker, B. Wilfond, G. Grana, M. B. Daly, K. Schneider, and M. J. E. Kahn Genetic Testing for Susceptibility to Adult-Onset Cancer: The Process and Content of Informed Consent JAMA, May 14, 1997; 277(18): 1467 - 1474. [Abstract] [PDF]

				L. K. Andersen, H. K. Jensen, S. Juul, and O. Faergeman Patients' Attitudes Toward Detection of Heterozygous Familial Hypercholesterolemia Arch Intern Med, March 10, 1997; 157(5): 553 - 560. [Abstract] [PDF]

				C. Lerman, S. Narod, K. Schulman, C. Hughes, A. Gomez-Caminero, G. Bonney, K. Gold, B. Trock, D. Main, J. Lynch, et al. BRCA1 Testing in Families With Hereditary Breast-Ovarian Cancer: A Prospective Study of Patient Decision Making and Outcomes JAMA, June 26, 1996; 275(24): 1885 - 1892. [Abstract] [PDF]